Lattice Medical
3D printed bioresorbable breast implants enabling natural tissue regeneration after cancer
- CEO / Founder
- Julien Payen
- Team Size
- 51-200
- Stage
- Active
- Total Funding
- €63.4M
- Latest Round
- Series B
- Key Investors
- Bpifrance SPI Fund, EIC Fund, Blast.Club, SPRIM Global Investments, TIDJEE, Captech Santé, Nord France Amorçage, FIRA Nord Est
Technology & Products
Key Products
3D printed bioresorbable breast implants (MatrixSafe) that enable natural tissue regeneration after cancer.
Technological Advantage
Unique 3D printing technology for resorbable implants with controlled manufacturing facility
Differentiation
Value Proposition
Natural breast reconstruction using 3D printed resorbable scaffold that allows patients own tissue to regenerate
How They Differentiate
Only fully resorbable 3D printed implant enabling natural tissue regeneration
Market & Competition
Target Customers
Breast cancer patients, oncological surgeons, hospitals
Industry Verticals
Medical Devices, Oncology, Breast Reconstruction, Healthcare
Competitors
Traditional silicone implant manufacturers, autologous tissue reconstruction
Growth & Milestones
Growth Metrics
Clinical trials ongoing, manufacturing facility operational since 2020
Major Milestones
Founded 2017, €3.6M early funding, Manufacturing facility (2020), Clinical trials launch, €43M Series B (2025)
Notable Customers
Clinical trial hospitals in France and Spain